CFTR Gene Variant Detection in Moroccan Individuals via Nanopore Long-Read Sequencing

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Cystic fibrosis (CF) is an autosomal recessive disease resulting from pathogenic CF transmembrane conductance regulator ( CFTR ) pathogenic gene variants. While CF’s frequency varies among ethnicities, its epidemiology, clinical manifestations, and mutational profiles in Africa still must be explored due to the absence of a comprehensive public health strategy there. This study postulates that complete sequencing of CFTR using Oxford Nanopore Technology (ONT)-based long-read sequencing enhances the diagnostic yield.

Methods

To amplify ∼25-kb fragments covering the whole CFTR gene (NM_000492.4), we designed 11 primer pairs, and barcoded libraries were prepared and sequenced on ONT flow cells (R10.4.1) using an Mk1C device. Variant pathogenicity was assessed by expressing the variant channel in HEK293 cells and examining expression through immuno-blotting.

Results

With sequencing data obtained from 9 Moroccan individuals (6 probands with suspected CF diagnoses and 3 parents), we identified the following variants: c.680T>G p.Leu227Arg, c.1521_1523del p.Phe508del, c.3484C>T p.Arg1162*, c.1090T>C p.Ser364Pro, c.3233T>C p.Phe1078Ser and c.2991G>C p.Leu997Phe. The analytical pipeline we developed allowed the phasing of the variants. Sanger sequencing confirmed all these results. The previously uncharacterised CFTR variants p.Ser364Pro and p.Phe1078Ser exhibit diminished expression in HEK293 cells, substantiating their pathogenic nature, with p.Phe1078Ser responding positively to the in vitro treatment with CFTR-modulator molecules.

Conclusions

This study demonstrates the potential of long-read sequencing using ONT as an efficient means to detect CF-causing variants in African populations. Given the significant genetic heterogeneity in Africa, this technique can serve as an affordable molecular screening tool for CF, especially in areas with constrained access to genetic screening.

Highlights

  • Here, we demonstrate the efficiency of sequencing the complete CFTR gene using Oxford Nanopore Technology, an information-rich and accurate method.

  • Not-yet-reported CFTR variants of unknown significance were identified from a small cohort of nine cystic fibrosis patients and parents from Fez, Morocco.

  • The biochemical characterisation of the CFTR variants p.Ser364Pro, p.Phe1078Ser, and p.Leu997Phe highlights the importance of conducting expression studies when genetic variants are identified.

  • Our proposed approach will enhance diagnostic outcomes, particularly in populations with significant genetic diversity, such as those in Africa.

Article activity feed